Furthermore, studies indicate that inhibiting inflammatory signaling pathways can ameliorate COPD-induced depressive symptoms [32], further supporting TNFAIP3’s potential role in modulating inflammation and mental wellbeing. The gene discussed is TNFAIP3; the disease is chronic obstructive pulmonary disease.